Studies bacterial DNA topology and type II topoisomerases, combining biochemistry, biophysics, and pharmacology to define mechanisms of action, resistance, and target engagement. His lab advances and evaluates next‑generation antimicrobials to address drug‑resistant infections and guide clinical candidates.